NewAmsterdam Pharma Company N.V. NAMS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • NL • USD

SharesGrow Score

60/100

3/7 Pass

SharesGrow Intrinsic Value

Ha habido 50 transacciones internas recientes registradas para NewAmsterdam Pharma Company N.V. (NAMS), incluyendo 17 compras y 31 ventas. El total de compras internas fue valorado en $13.79M y el total de ventas internas en $42.35M.

Internos destacados con actividad reciente incluyen Lange Louis G, Kastelein Johannes Jacob Pieter, Davidson Michael H.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.

Operaciones de Insiders — NAMS

Fecha	Nombre	Cargo	Tipo de Transacción	Acciones	Precio Promedio	Valor	Acciones en Propiedad
2026-03-11	Lange Louis G	Director	Venta Informativa	446	$31.23	$13.93K	10,360
2026-03-09	Kastelein Johannes Jacob Pieter	Chief Scientific Officer	Venta Informativa	101,409	$30.29	$3.07M	69,302
2026-03-09	Lange Louis G	Director	Ejercicio de Opciones (ITM)	44,619	$11.50	$513.12K	-
2026-03-06	Kastelein Johannes Jacob Pieter	Chief Scientific Officer	Venta Informativa	94,124	$30.32	$2.85M	69,302
2026-03-06	Lange Louis G	Director	Venta Informativa	28,186	$29.41	$828.95K	-
2026-03-05	Kastelein Johannes Jacob Pieter	Chief Scientific Officer	Venta Informativa	104,467	$30.30	$3.17M	69,302
2026-03-02	Davidson Michael H.	Chief Executive Officer	Venta Informativa	443,707	$33.25	$14.75M	174,144
2026-02-26	Davidson Michael H.	Chief Executive Officer	Venta Informativa	17,924	$34.44	$617.3K	174,144
2026-02-25	Davidson Michael H.	Chief Executive Officer	Venta Informativa	1,300	$36.68	$47.68K	459,859
2026-02-24	Davidson Michael H.	Chief Executive Officer	Venta Informativa	3,161	$36.46	$115.25K	459,859
2026-02-20	Kastelein Johannes Jacob Pieter	Chief Scientific Officer	Venta Informativa	30,789	$35.46	$1.09M	53,500
2026-01-28	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	32,612	$31.80	$1.04M	24,353
2026-01-27	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	39,816	$32.62	$1.3M	24,353
2026-01-26	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	309	$33.45	$10.34K	24,353
2026-01-23	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	12,767	$34.37	$438.8K	24,353
2026-01-21	Somaiya Mayur Ian	Chief Financial Officer	Venta Informativa	24,362	$33.80	$823.44K	58,382
2026-01-20	Somaiya Mayur Ian	Chief Financial Officer	Venta Informativa	19,604	$32.38	$634.78K	58,382
2026-01-07	Somaiya Mayur Ian	Chief Financial Officer	Concesión de RSU	25,500	-	-	58,382
2026-01-07	Kastelein Johannes Jacob Pieter	Chief Scientific Officer	Concesión de RSU	25,500	-	-	98,981
2026-01-07	Kooij Louise Frederika	Chief Accounting Officer	Concesión de RSU	12,000	-	-	24,353
2026-01-07	Lange Louis G	Director	Concesión de RSU	3,400	-	-	10,360
2026-01-07	Lewis William	Director	Concesión de RSU	3,400	-	-	10,360
2026-01-07	Smither John W	Director	Concesión de RSU	3,400	-	-	10,360
2026-01-07	Davidson Michael H.	Chief Executive Officer	Concesión de RSU	364,000	$35.45	$12.9M	364,000
2026-01-07	Gulfo Adele M.	Director	Concesión de RSU	3,400	-	-	14,260
2026-01-07	Mckenna Mark C.	Director	Concesión de RSU	3,400	-	-	10,360
2026-01-07	Van Der Kamp Hilde Johanna	Director	Concesión de RSU	3,400	-	-	10,360
2026-01-05	Somaiya Mayur Ian	Chief Financial Officer	Venta Informativa	5,118	$33.25	$170.17K	32,882
2026-01-05	Kastelein Johannes Jacob Pieter	Chief Scientific Officer	Venta Informativa	6,000	$33.25	$199.5K	73,481
2026-01-05	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	2,647	$33.25	$88.01K	12,353
2025-12-26	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	43,872	$35.30	$1.55M	15,000
2025-12-24	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	26,011	$35.68	$928.07K	15,000
2025-12-23	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	75,117	$36.21	$2.72M	15,000
2025-09-15	Topper James N	Director	Compra Informativa	660	$23.70	$15.64K	3,028,524
2025-09-09	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	96,896	$26.11	$2.53M	15,000
2025-09-08	Topper James N	Director	Compra Informativa	1,260	$24.99	$31.49K	3,027,864
2025-09-03	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	18,073	$25.09	$453.45K	15,000
2025-09-02	Kooij Louise Frederika	Chief Accounting Officer	Ejercicio de Opciones (Venta)	18,073	-	-	-
2025-08-25	Kooij Louise Frederika	Chief Accounting Officer	Venta Informativa	8,269	$24.86	$205.57K	15,000
2025-06-25	Topper James N	Director	Compra Informativa	1,260	$18.26	$23.01K	3,026,133
2025-06-24	Topper James N	Director	Compra Informativa	2,520	$18.43	$46.45K	3,024,873
2025-06-16	Topper James N	Director	Compra Informativa	8,584	$19.50	$167.38K	3,022,153
2025-06-16	Kling Douglas F	Chief Operating Officer	Venta Informativa	18,109	$19.75	$357.65K	44,000
2025-06-01	Lange Louis G	Director	Ejercicio de Opciones (Venta)	68	-	-	-
2025-06-01	Marino Michael F Iii	See Remarks	Concesión de RSU	55,000	-	-	55,000
2025-05-27	Marino Michael F Iii	Officer	Desconocido	-	-	-	-
2025-05-15	Kling Douglas F	Chief Operating Officer	Venta Informativa	100,000	$18.38	$1.84M	44,000
2025-05-01	Lange Louis G	Director	Ejercicio de Opciones (Venta)	69	-	-	68
2025-05-01	Audet Juliette Berangere	See Remarks	Concesión de RSU	30,000	$20.03	$600.9K	30,000
2025-04-15	Gulfo Adele M.	Officer	Desconocido	-	-	-	-

■ Informativa — transacción en mercado abierto (más significativa) ■ No informativa (compra) — premio, ejercicio de opción, conversión ■ No informativa (venta) — retención fiscal, venta de adjudicación ■ Neutral — regalo, fideicomiso, vencimiento